Profil
Mr. Ashley A. Woodcock is a Chairman at Axalbion SA and a Chairman at Axalbion Therapeutics Ltd. He is on the Board of Directors at North West Lung Centre.
Mr. Woodcock was previously employed as a Non-Executive Chairman by Reacta Biotech Ltd.
Aktive Positionen von Ashley Arthur Woodcock
| Unternehmen | Position | Beginn |
|---|---|---|
North West Lung Centre
North West Lung Centre Medical/Nursing ServicesHealth Services Provides Other human health activities services | Direktor/Vorstandsmitglied | - |
Axalbion SA | Vorsitzender | - |
Axalbion Therapeutics Ltd.
Axalbion Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical-stage pharmaceutical company that developing TRPM8 agonists for the treatment of chronic cough and dry eyes | Vorsitzender | - |
Ehemalige bekannte Positionen von Ashley Arthur Woodcock
| Unternehmen | Position | Ende |
|---|---|---|
Reacta Biotech Ltd.
Reacta Biotech Ltd. Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and supplies oral food materials and technologies to pharmaceuticals | Gründer | 19.02.2026 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Reacta Biotech Ltd.
Reacta Biotech Ltd. Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and supplies oral food materials and technologies to pharmaceuticals | Commercial Services |
North West Lung Centre
North West Lung Centre Medical/Nursing ServicesHealth Services Provides Other human health activities services | Health Services |
Axalbion SA | |
Axalbion Therapeutics Ltd.
Axalbion Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical-stage pharmaceutical company that developing TRPM8 agonists for the treatment of chronic cough and dry eyes | Health Technology |
















